Czech Republic: Opinion of the SÚKL Department of Clinical Trials on ongoing clinical trials and on clinical trials not yet initiated in relation to COVID-19

2024-02-02T10:24:34+00:00June 30th, 2020|Categories: Clinical Trial, Covid-19, Eastern Europe, Europe, Regulatory|Tags: , , , |

The Czech Authority State Institute for Drug Control (SÚKL) updated its general recommendations respecting the current epidemiological situation with coronavirus regarding ongoing or not yet started clinical trials and the release of emergency measures of the government. This opinion [...]

Czech Republic Authority SÚKL issues clinical trial instructions for subject safety and data validity during COVID-19 emergency

2024-02-02T10:16:28+00:00March 16th, 2020|Categories: Eastern Europe, Europe|Tags: , , , , , |

The Czech Authority  State Institute for Drug Control (SÚKL) has issued an opinion on a clinical research under current COVID-19 pandemic on 13 March and provided additional clarifications regarding the management of patients visits and study products on 16 [...]

Go to Top